Dietary fatty acids and bioactive fatty acid metabolites in alcoholic liver disease
Alcoholic liver disease (ALD) comprises a spectrum of liver pathology, including steatosis, steatohepatitis, and cirrhosis. Previous work from our group and others suggests that dietary fat, both the amount and composition, plays a pivotal role in ALD development and progression; however, the impact...
Main Authors: | Kara H. Zirnheld, Dennis R. Warner, Jeffrey B. Warner, Josiah E. Hardesty, Craig J. McClain, Irina A. Kirpich |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-12-01
|
Series: | Liver Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542568419300467 |
Similar Items
-
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
by: Jeffrey Warner, et al.
Published: (2020-06-01) -
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury
by: Dennis Warner, et al.
Published: (2021-06-01) -
Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
by: Jeffrey Warner, et al.
Published: (2021-08-01) -
<i>Fpr2</i><sup>−/−</sup> Mice Developed Exacerbated Alcohol-Associated Liver Disease
by: Josiah E. Hardesty, et al.
Published: (2023-04-01) -
Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
by: Jeffrey B. Warner, et al.
Published: (2022-01-01)